Note: Sherlock Biosciences's revenues are gauged from an analysis of company filings.
Sherlock Biosciences's Income Statement (based on Industry Averages)
Sherlock Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Sherlock Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
March 15, 2022
13
100%
$80 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Sherlock Biosciences is developing and marketing.
Sherlock Biosciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
LAB DETECTIVE Diagnostic medical testing kits for home use testing for sexually transmitted infections, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; diagnostic medical testing kits for prenatal testing, fetal trait testing, and gender identification testing
09/21/2023
LUMILAB Diagnostic medical testing kits for home use testing for sexually transmitted infections, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; diagnostic medical testing kits for prenatal testing, fetal trait testing, and gender identification testing
09/21/2023
CLUEDIN Diagnostic medical testing kits for home use testing for sexually transmitted infections, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; diagnostic medical testing kits for prenatal testing, fetal trait testing, and gender identification testing
09/21/2023
See all trademarks and details in the Full Report.
Market Share of Sherlock Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Sherlock Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Sherlock Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Sherlock Biosciences's Fastest Growing Competitors
These companies are in the same general field as Sherlock Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.